351 related articles for article (PubMed ID: 26385729)
1. The changing relationship between HbA1c and FPG according to different FPG ranges.
Guan X; Zheng L; Sun G; Guo X; Li Y; Song H; Tian F; Sun Y
J Endocrinol Invest; 2016 May; 39(5):523-8. PubMed ID: 26385729
[TBL] [Abstract][Full Text] [Related]
2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
[TBL] [Abstract][Full Text] [Related]
4. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
[TBL] [Abstract][Full Text] [Related]
5. Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians.
Marini MA; Succurro E; Arturi F; Ruffo MF; Andreozzi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G
Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):561-6. PubMed ID: 21944738
[TBL] [Abstract][Full Text] [Related]
6. Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults.
Lee J; Lee YA; Kim JH; Lee SY; Shin CH; Yang SW
Diabetes Metab J; 2019 Apr; 43(2):174-182. PubMed ID: 30398041
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study.
Rathmann W; Kowall B; Tamayo T; Giani G; Holle R; Thorand B; Heier M; Huth C; Meisinger C
Ann Med; 2012 Mar; 44(2):170-7. PubMed ID: 21091229
[TBL] [Abstract][Full Text] [Related]
8. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
[TBL] [Abstract][Full Text] [Related]
9. Anthropometry did not approach adequate predictive accuracies for detecting elevated fasting plasma glucose or hemoglobin A1c levels among Chinese children aged 7-9 years.
You YB; Zhou H; Han J; Zhu YH; Zan D; Zhang QY
J Diabetes Investig; 2021 May; 12(5):781-789. PubMed ID: 32881410
[TBL] [Abstract][Full Text] [Related]
10. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
11. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.
Kharroubi AT; Darwish HM; Abu Al-Halaweh AI; Khammash UM
PLoS One; 2014; 9(2):e88123. PubMed ID: 24505401
[TBL] [Abstract][Full Text] [Related]
13. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
[TBL] [Abstract][Full Text] [Related]
15. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
[TBL] [Abstract][Full Text] [Related]
16. Effects of sex, age and BMI on screening tests for impaired glucose tolerance.
Gomyo M; Sakane N; Kamae I; Sato S; Suzuki K; Tominaga M; Kawazu S; Yoshinaga H; Tsushita K; Sato J; Sato Y; Tsujii S; Yoshida T; Seino Y; Usui T; Nanjo K; Hirata M; Kotani K; Hososako A; Kiyohara Y; Kuzuya H
Diabetes Res Clin Pract; 2004 May; 64(2):129-36. PubMed ID: 15063606
[TBL] [Abstract][Full Text] [Related]
17. Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.
Bachmann MO; Lewis G; John WG; Turner J; Dhatariya K; Clark A; Pascale M; Sampson M;
Diabet Med; 2019 Nov; 36(11):1478-1486. PubMed ID: 31420897
[TBL] [Abstract][Full Text] [Related]
18. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
Tsuji I; Nakamoto K; Hasegawa T; Hisashige A; Inawashiro H; Fukao A; Hisamichi S
Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
[TBL] [Abstract][Full Text] [Related]
19. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
Davidson MB; Schriger DL; Peters AL; Lorber B
JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
[TBL] [Abstract][Full Text] [Related]
20. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
